271 to 280 of 800 Results
Comma Separated Values - 4.1 KB -
MD5: 3fb1dbc65fe7fc08e04d3b22413dd6fc
|
Comma Separated Values - 53.2 KB -
MD5: fa9db09a6c7bb4913ff724f58fc89804
|
Comma Separated Values - 1.8 KB -
MD5: 2d9e24232a8e9ca81d055baeb21ad4c7
|
Comma Separated Values - 53.2 KB -
MD5: df2fc111ae0fafa06bd973e74222b68a
|
Comma Separated Values - 6.1 KB -
MD5: 4708c9eef03c4b1d5b507863b629382b
|
Comma Separated Values - 53.2 KB -
MD5: 1121638b88369aa95c3a25a3c041b2b4
|
Comma Separated Values - 5.8 KB -
MD5: a6b5762cb8ce7157bf7c95fbc3f44ed4
|
Comma Separated Values - 53.2 KB -
MD5: a01784f03b6d48cb6e90fbc981e8f4b9
|
Sep 6, 2022 - DiTECT-HAT
Lejon, Veerle; Ngay Lukusa, Ipos; Mumba Ngoyi, Dieudonné; Van Reet, Nick; Buscher, Philippe, 2022, "Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP4 Early test-of-cure", https://doi.org/10.23708/MBMROD, DataSuds, V2
In the last decade, the prevalence of Trypanosoma brucei gambiense human African trypanosomiasis (HAT) has fallen and HAT has been targeted for elimination. Clinical trials on safe and efficacious drugs for HAT, applicable in an elimination context, would be accelerated by availa... |
Sep 6, 2022 -
Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP4 Early test-of-cure
MS Word - 25.1 KB -
MD5: ebb2dc6dc63e3b4c9d6ed4f9cb660bc0
Addendum to DiTECT-HAT-WP4 protocol (august 2020) |
